Randomised Study of Azacitidine Versus Azacitidine With Vorinostat in Patients With AML or High Risk MDS
Clinical trial NCT01617226 · COMPLETED
Trial details
- NCT number
- NCT01617226
- Sponsor
- University of Birmingham
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2016-03-01
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.